Eam Global Investors LLC Zai Lab LTD Transaction History

Eam Global Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$126.27 - $191.71 $3.98 Million - $6.04 Million	-31,487 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$81.94 - $135.34 $1.79 Million - $2.96 Million	21,864 Added 227.21%	31,487 $4.26 Million
Q3 2020 Nov 13, 2020	SELL	$73.3 - $89.48 $13,780 - $16,822	-188 Reduced 1.92%	9,623 $800,000
Q2 2020 Aug 13, 2020	SELL	$48.82 - $82.53 $374,156 - $632,509	-7,664 Reduced 43.86%	9,811 $806,000
Q1 2020 May 13, 2020	BUY	$39.1 - $62.9 $683,272 - $1.1 Million	17,475 New	17,475 $900,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.63B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.